跳至主要内容
临床试验/JPRN-UMIN000039444
JPRN-UMIN000039444招募中1 期

Phase I dose-escalation study of stereotactic body radiation therapy for prostate cancer - Phase I dose-escalation study of stereotactic body radiation therapy for prostate cancer

The University of Tokyo0 个研究点目标入组 72 人开始时间: 2020年2月10日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • a) Refusal to participate b) Lymph node or distant metastasis c) History of treatment except hormone therapy for prostate cancer d) History of radiotherapy for pelvic region e) Inflammatory bowel disease like ulcerative colitis and Crohn's disease f) History of surgery for rectal disease g) Participants of other clinical trial that may affect the result of this study h) Ineligible patients judged by investigators Following patients were ineligible for injection of hydrogel spacer i) Difficult to insert the ultrasound probe into the rectum j) Allergic to local anesthetic agents k) Rectum invasion or dorsal extracapsular invasion

研究者

相似试验

终止
不适用
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck CancerRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharyngeal Keratinizing Squamous Cell CarcinomaRecurrent Oral Cavity Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell CarcinomaStage II Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell CarcinomaStage III Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaStage III Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage III Oral Cavity Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell CarcinomaStage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Hypopharyngeal Squamous Cell CarcinomaStage IVB Laryngeal Squamous Cell CarcinomaStage IVB Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage IVB Oral Cavity Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell CarcinomaStage IVC Hypopharyngeal Squamous Cell CarcinomaStage IVC Laryngeal Squamous Cell CarcinomaStage IVC Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage IVC Oral Cavity Squamous Cell CarcinomaStage IVC Oropharyngeal Squamous Cell Carcinoma
NCT02388932Case Comprehensive Cancer Center3
已完成
1 期
Phase I study of stereotactic body radiation therapy (SBRT) for stage IA, centrally located non-small cell lung cancerstage IA non-small cell lung cancer
JPRN-UMIN000004100Japanese Radiation Oncology Study Group(JROSG)30
已完成
不适用
Stereotactic Body Radiation Therapy (SBRT) for Liver MetsLiver Metastases
NCT01360606Susannah Ellsworth9
已完成
1 期
A phase I clinical trial of stereotactic body radiotherapy for patients with cervical cancer unsuitable for intracavitary brachytherapyCervical cancer
JPRN-UMIN000020519Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital12
已完成
1 期
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.lung tumor
JPRN-UMIN000005061Department of Radiology, Nagoya City University Graduate School of Medical Sciences35
Phase I dose-escalation study of stereotactic body... | 临床试验